Spirox, Inc.

📍 Redwood City, United States🗓 Founded 2012👥 13 employees💰 Last funded Mar 2016
Spirox is committed to improving the quality of life for patients suffering from nasal obstruction, a condition that affects more than 20 million individuals in the United States. The Menlo Park-based company’s first product—the LATERA absorbable nasal implant—is designed to address one of the most common, yet undertreated, causes of nasal obstruction today, nasal valve collapse (NVC). For more information, please visit www.spiroxmed.com. LATERA is available in the U.S. only. Spirox and LATERA and its logos are trademarks of Spirox, Inc.
2
Total investors
0
Early stage
2
Mid stage
0
Late stage
2012
Founded
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Spirox, Inc.?
Spirox, Inc. has 2 investors on record on gritt.io, 2 mid-stage.
When did Spirox, Inc. last raise funding?
The most recent investment in Spirox, Inc. recorded on gritt.io was in March 2016.
When was Spirox, Inc. founded?
Spirox, Inc. was founded in 2012.
What industry is Spirox, Inc. in?
Spirox, Inc. operates in Medical Devices. Find similar Medical Devices investors on gritt.io.
Where is Spirox, Inc. based?
Spirox, Inc. is headquartered in Redwood City, United States.